Welcome to the BioLogicTube jeo@biologicmedia.dk https://biologictube.dk/app/facebook en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Welcome to the BioLogicTube episodic no https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif https://biologictube.dk/app/facebook http://biologictube.dk/photo/6987021/biotechbuilders-2012 <p>BiotechBuilders is an informal and independent network organization for entrepreneurs and business professionals in the healthcare industry, and is based on the personal interaction between its members – Biotech entrepreneurs and business professionals, representatives from pharmaceutical companies and service providers with a special interest in the Biotech, Medtech and Diagnostic industry.</p> <p>The objective of BiotechBuilders is to facilitate growth in the industry through establishment of personal contacts that will transform into an exchange of ideas, know-how and development activities and ultimately stimulate the creation of new projects and companies.</p> <p>True BiotechBuilders are eager to network, partner, learn from each other and help one another to become successful. This is based on trust and the commitment to add mutually beneficial value to each other, now and in the future.</p> <p>Since BiotechBuilders is not promoting any specific organisational or political interests, be it global, regional or local, its members can address everything openly, sharing strengths and weaknesses, being critical, being provoking. The trust that is built through true “behind the scenes” sharing brings people close to each other and into the space where new ideas and initiatives are being conceived.</p> <p>Our long-term goal is to build strong competencies, including highest modern management standards for the established players in the industry and a learning platform for start-up entrepreneurs, all with a view to securing strong international collaboration, based on professionalism and mutual credibility. Bringing key players in the industry together, and allowing them to exchange experiences and key learnings in a not-everyday environment (see our Events), is crucial in this process.</p> <p>BiotechBuilders has a strong focus on the individual and his/her capabilities; no short-term business needs and discussions between the VP of A with the COO of B are the focus, but long-term goals with high impact on the growth and maturation of our industry and its leaders.</p> <p>Born in Medicon Valley in 2002, the BiotechBuilders network and Annual Event has attracted international attention and further regional BiotechBuilders “clusters” are being built: Stockholm and London are number two and three. The close personal interaction is maintained in the regional settings, and regional clusters are linked into an international network through www.biotechbuilders.com.</p><p><a href="http://biologictube.dk/photo/6987021/biotechbuilders-2012"><img src="http://biologictube.dk/4959050/6987021/69c2fb9b7858964700038ce459d9a91f/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/6987021 Thu, 06 Sep 2012 15:56:50 GMT BiotechBuilders 2012 BiotechBuilders is an informal and independent network organization for entrepreneurs and business professionals in the healthcare industry, and is based on the personal interaction between its members – Biotech entrepreneurs and business professionals, representatives from pharmaceutical companies and service providers with a special interest in the Biotech, Medtech and Diagnostic industry. The objective of BiotechBuilders is to facilitate growth in the industry through establishment of personal contacts that will transform into an exchange of ideas, know-how and development activities and ultimately stimulate the creation of new projects and companies. True BiotechBuilders are eager to network, partner, learn from each other and help one another to become successful. This is based on trust and the commitment to add mutually beneficial value to each other, now and in the future. Since BiotechBuilders is not promoting any specific organisational or political interests, be it global, regional or local, its members can address everything openly, sharing strengths and weaknesses, being critical, being provoking. The trust that is built through true “behind the scenes” sharing brings people close to each other and into the space where new ideas and initiatives are being conceived. Our long-term goal is to build strong competencies, including highest modern management standards for the established players in the industry and a learning platform for start-up entrepreneurs, all with a view to securing strong international collaboration, based on professionalism and mutual credibility. Bringing key players in the industry together, and allowing them to exchange experiences and key learnings in a not-everyday environment (see our Events), is crucial in this process. BiotechBuilders has a strong focus on the individual and his/her capabilities; no short-term business needs and discussions between the VP of A with the COO of B are the focus, but long-term goals with high impact on the growth and maturation of our industry and its leaders. Born in Medicon Valley in 2002, the BiotechBuilders network and Annual Event has attracted international attention and further regional BiotechBuilders “clusters” are being built: Stockholm and London are number two and three. The close personal interaction is maintained in the regional settings, and regional clusters are linked into an international network through www.biotechbuilders.com. BiotechBuilders is an informal and independent network organization for entrepreneurs and business professionals in the healthcare industry, and is based on the personal interaction between its members – Biotech entrepreneurs and business... Welcome to the BioLogicTube 03:58 <p>BiotechBuilders is an informal and independent network organization for entrepreneurs and business professionals in the healthcare industry, and is based on the personal interaction between its members – Biotech entrepreneurs and business professionals, representatives from pharmaceutical companies and service providers with a special interest in the Biotech, Medtech and Diagnostic industry.</p> <p>The objective of BiotechBuilders is to facilitate growth in the industry through establishment of personal contacts that will transform into an exchange of ideas, know-how and development activities and ultimately stimulate the creation of new projects and companies.</p> <p>True BiotechBuilders are eager to network, partner, learn from each other and help one another to become successful. This is based on trust and the commitment to add mutually beneficial value to each other, now and in the future.</p> <p>Since BiotechBuilders is not promoting any specific organisational or political interests, be it global, regional or local, its members can address everything openly, sharing strengths and weaknesses, being critical, being provoking. The trust that is built through true “behind the scenes” sharing brings people close to each other and into the space where new ideas and initiatives are being conceived.</p> <p>Our long-term goal is to build strong competencies, including highest modern management standards for the established players in the industry and a learning platform for start-up entrepreneurs, all with a view to securing strong international collaboration, based on professionalism and mutual credibility. Bringing key players in the industry together, and allowing them to exchange experiences and key learnings in a not-everyday environment (see our Events), is crucial in this process.</p> <p>BiotechBuilders has a strong focus on the individual and his/her capabilities; no short-term business needs and discussions between the VP of A with the COO of B are the focus, but long-term goals with high impact on the growth and maturation of our industry and its leaders.</p> <p>Born in Medicon Valley in 2002, the BiotechBuilders network and Annual Event has attracted international attention and further regional BiotechBuilders “clusters” are being built: Stockholm and London are number two and three. The close personal interaction is maintained in the regional settings, and regional clusters are linked into an international network through www.biotechbuilders.com.</p><p><a href="http://biologictube.dk/photo/6987021/biotechbuilders-2012"><img src="http://biologictube.dk/4959050/6987021/69c2fb9b7858964700038ce459d9a91f/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Jorgen Jørgen Thorball biotek medical medicon medtech networking scandinavian valley http://biologictube.dk/photo/3228526/pharmacosmos-cro <p>Pharmacosmos CRO<br /> Unique access to optimized global development<br /> We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies:<br /> • Integrated development planning through a senior development team<br /> • Patient recruitment in key global geographies through validated partners<br /> • Flexibility and agility of an SME<br /> • Global regulatory track record<br /> • Single point of contact<br /> We have a track record for bringing new products from concept through to commercialization together with our dedicated and validated partner network.<br /> We have achieved registrations in more than 50 countries and registration times of less than 3 years from first-in-human to first registration.<br /> Our team provides the optimal solution to secure your specific milestones and regulatory objectives to satisfy your investors. What ever your needs, we always focus on delivering high quality solutions</p> <p>Our approach<br /> Optimizing global medical product development<br /> Our approach is to keep an in-house team of development executives to handle the strategic planning and manage plan execution. Execution is done through a global network of validated and audited partners.<br /> For European biotech companies this approach maximize the value creation through<br /> • Easy access to a seasoned VP team of developers<br /> • Track record from CMC through to commercialization<br /> • Insight and experience to obtain key regulatory buy in from FDA and EMA<br /> • Patient recruitment in key global geographies<br /> For European pharmaceutical companies we add value through<br /> • Combining European, US and Indian core competences when executing your studies<br /> • Guiding and managing functional outsourcing of clinical development services<br /> • Obtaining and maintaining global registrations through our network<br /> This way we accelerate clinical development at reduced cost, add flexibility, and help companies expand their commercialization to the global market place.<br /> <br /> <br /> Our team<br /> Identifying the most optimal plan to achieve your specific development goals<br /> Pharmacosmos CRO offers access to a seasoned VP team of developers spanning from CMC through to commercialization. Together, our team helps develop the most optimal plan to secure your specific development goals.</p> <p>Primary contact<br /> Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD</p> <p>Our VP team<br /> Claes Christian Strom 
Vice President, Medical Affairs
MD, PhD, BBA</p> <p>Lars Lykke Thomsen
 Vice President, Chief Medical Officer
MD, PhD, DMSc</p> <p>Kim Nordfjeld 
 Vice President, Quality and Registration
PhD Pharmacy</p> <p>Jens Fabricius
 Vice President, Marketing and Business Operations
BCommerce, EMBA</p> <p>Robert Guglielmetti 
Executive Vice President, Chief Financial Officer
MSc Accounting<br /> <br /> <br /> To learn more about Pharmacosmos CRO and our ability to secure your development milestone, please contact Jeppe Skytte:<br /> Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD

T: +45 59 48 59 85 (direct)
T: +45 22 84 26 56 (mobile)
E: <a href="mailto:jsk@pharmacosmos.com">jsk@pharmacosmos.com</a><br /> Pharmacosmos CRO offices<br /> Pharmacosmos CRO A/S
Roervangsvej 30
DK-4300 Holbaek
Denmark<br /> Learn more about Pharmacosmos<br /> Visit our corporate website: www.pharmacosmos.com</p><p><a href="http://biologictube.dk/photo/3228526/pharmacosmos-cro"><img src="http://biologictube.dk/1984076/3228526/15181a34c38814f1299eaa0872884484/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/3228526 Fri, 09 Sep 2011 16:45:51 GMT Pharmacosmos CRO Pharmacosmos CRO Unique access to optimized global development We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies: • Integrated development planning through a senior development team • Patient recruitment in key global geographies through validated partners • Flexibility and agility of an SME • Global regulatory track record • Single point of contact We have a track record for bringing new products from concept through to commercialization together with our dedicated and validated partner network. We have achieved registrations in more than 50 countries and registration times of less than 3 years from first-in-human to first registration. Our team provides the optimal solution to secure your specific milestones and regulatory objectives to satisfy your investors. What ever your needs, we always focus on delivering high quality solutions Our approach Optimizing global medical product development Our approach is to keep an in-house team of development executives to handle the strategic planning and manage plan execution. Execution is done through a global network of validated and audited partners. For European biotech companies this approach maximize the value creation through • Easy access to a seasoned VP team of developers • Track record from CMC through to commercialization • Insight and experience to obtain key regulatory buy in from FDA and EMA • Patient recruitment in key global geographies For European pharmaceutical companies we add value through • Combining European, US and Indian core competences when executing your studies • Guiding and managing functional outsourcing of clinical development services • Obtaining and maintaining global registrations through our network This way we accelerate clinical development at reduced cost, add flexibility, and help companies expand their commercialization to the global market place. Our team Identifying the most optimal plan to achieve your specific development goals Pharmacosmos CRO offers access to a seasoned VP team of developers spanning from CMC through to commercialization. Together, our team helps develop the most optimal plan to secure your specific development goals. Primary contact Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD Our VP team Claes Christian Strom 
Vice President, Medical Affairs
MD, PhD, BBA Lars Lykke Thomsen
 Vice President, Chief Medical Officer
MD, PhD, DMSc Kim Nordfjeld 
 Vice President, Quality and Registration
PhD Pharmacy Jens Fabricius
 Vice President, Marketing and Business Operations
BCommerce, EMBA Robert Guglielmetti 
Executive Vice President, Chief Financial Officer
MSc Accounting To learn more about Pharmacosmos CRO and our ability to secure your development milestone, please contact Jeppe Skytte: Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD

T: +45 59 48 59 85 (direct)
T: +45 22 84 26 56 (mobile)
E: jsk@pharmacosmos.com Pharmacosmos CRO offices Pharmacosmos CRO A/S
Roervangsvej 30
DK-4300 Holbaek
Denmark Learn more about Pharmacosmos Visit our corporate website: www.pharmacosmos.com Pharmacosmos CRO Unique access to optimized global development We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies: • Integrated development planning through a senior... Welcome to the BioLogicTube 01:02 <p>Pharmacosmos CRO<br /> Unique access to optimized global development<br /> We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies:<br /> • Integrated development planning through a senior development team<br /> • Patient recruitment in key global geographies through validated partners<br /> • Flexibility and agility of an SME<br /> • Global regulatory track record<br /> • Single point of contact<br /> We have a track record for bringing new products from concept through to commercialization together with our dedicated and validated partner network.<br /> We have achieved registrations in more than 50 countries and registration times of less than 3 years from first-in-human to first registration.<br /> Our team provides the optimal solution to secure your specific milestones and regulatory objectives to satisfy your investors. What ever your needs, we always focus on delivering high quality solutions</p> <p>Our approach<br /> Optimizing global medical product development<br /> Our approach is to keep an in-house team of development executives to handle the strategic planning and manage plan execution. Execution is done through a global network of validated and audited partners.<br /> For European biotech companies this approach maximize the value creation through<br /> • Easy access to a seasoned VP team of developers<br /> • Track record from CMC through to commercialization<br /> • Insight and experience to obtain key regulatory buy in from FDA and EMA<br /> • Patient recruitment in key global geographies<br /> For European pharmaceutical companies we add value through<br /> • Combining European, US and Indian core competences when executing your studies<br /> • Guiding and managing functional outsourcing of clinical development services<br /> • Obtaining and maintaining global registrations through our network<br /> This way we accelerate clinical development at reduced cost, add flexibility, and help companies expand their commercialization to the global market place.<br /> <br /> <br /> Our team<br /> Identifying the most optimal plan to achieve your specific development goals<br /> Pharmacosmos CRO offers access to a seasoned VP team of developers spanning from CMC through to commercialization. Together, our team helps develop the most optimal plan to secure your specific development goals.</p> <p>Primary contact<br /> Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD</p> <p>Our VP team<br /> Claes Christian Strom 
Vice President, Medical Affairs
MD, PhD, BBA</p> <p>Lars Lykke Thomsen
 Vice President, Chief Medical Officer
MD, PhD, DMSc</p> <p>Kim Nordfjeld 
 Vice President, Quality and Registration
PhD Pharmacy</p> <p>Jens Fabricius
 Vice President, Marketing and Business Operations
BCommerce, EMBA</p> <p>Robert Guglielmetti 
Executive Vice President, Chief Financial Officer
MSc Accounting<br /> <br /> <br /> To learn more about Pharmacosmos CRO and our ability to secure your development milestone, please contact Jeppe Skytte:<br /> Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD

T: +45 59 48 59 85 (direct)
T: +45 22 84 26 56 (mobile)
E: <a href="mailto:jsk@pharmacosmos.com">jsk@pharmacosmos.com</a><br /> Pharmacosmos CRO offices<br /> Pharmacosmos CRO A/S
Roervangsvej 30
DK-4300 Holbaek
Denmark<br /> Learn more about Pharmacosmos<br /> Visit our corporate website: www.pharmacosmos.com</p><p><a href="http://biologictube.dk/photo/3228526/pharmacosmos-cro"><img src="http://biologictube.dk/1984076/3228526/15181a34c38814f1299eaa0872884484/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> CRO Christian Claes Fabricius Guglielmetti Jens Jeppe Kim Lars Lykke Nordfjeld Optimizing Pharmacosmos President Robert Skytte Strom Thomsen
 development global medical product 
Vice